IRIDEX Balance Sheet Health

Financial Health criteria checks 3/6

IRIDEX has a total shareholder equity of $2.6M and total debt of $2.8M, which brings its debt-to-equity ratio to 105.1%. Its total assets and total liabilities are $30.2M and $27.5M respectively.

Key information

105.1%

Debt to equity ratio

US$2.76m

Debt

Interest coverage ration/a
CashUS$3.86m
EquityUS$2.62m
Total liabilitiesUS$27.53m
Total assetsUS$30.15m

Recent financial health updates

Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth?

May 14
Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth?

Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Oct 04
Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Recent updates

Revenues Working Against IRIDEX Corporation's (NASDAQ:IRIX) Share Price Following 26% Dive

Jun 11
Revenues Working Against IRIDEX Corporation's (NASDAQ:IRIX) Share Price Following 26% Dive

Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth?

May 14
Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth?

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

Mar 28

Little Excitement Around IRIDEX Corporation's (NASDAQ:IRIX) Revenues

Feb 14
Little Excitement Around IRIDEX Corporation's (NASDAQ:IRIX) Revenues

Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Oct 04
Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Lacklustre Performance Is Driving IRIDEX Corporation's (NASDAQ:IRIX) 32% Price Drop

Aug 12
Lacklustre Performance Is Driving IRIDEX Corporation's (NASDAQ:IRIX) 32% Price Drop

Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

Apr 14
Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?

We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely

Oct 12
We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely

Is IRIDEX (NASDAQ:IRIX) Using Too Much Debt?

Feb 25
Is IRIDEX (NASDAQ:IRIX) Using Too Much Debt?

Iridex To Benefit From New Revolutionary Glaucoma Treatment

Jan 11

Analysts Expect Breakeven For IRIDEX Corporation (NASDAQ:IRIX) Before Long

Jan 03
Analysts Expect Breakeven For IRIDEX Corporation (NASDAQ:IRIX) Before Long

IRIDEX says laser therapy now accepted in the European Glaucoma Society guidelines

Dec 23

Financial Position Analysis

Short Term Liabilities: IRIX's short term assets ($24.3M) exceed its short term liabilities ($15.9M).

Long Term Liabilities: IRIX's short term assets ($24.3M) exceed its long term liabilities ($11.7M).


Debt to Equity History and Analysis

Debt Level: IRIX has more cash than its total debt.

Reducing Debt: IRIX's debt to equity ratio has increased from 0% to 105.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IRIX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: IRIX has less than a year of cash runway if free cash flow continues to grow at historical rates of 2.7% each year.


Discover healthy companies